Características clínicas, estadificación y tratamiento de los pacientes con carcinoma hepatocelular en la práctica clínica. Estudio prospectivo de una serie de 136 pacientes

Gómez Rodríguez, Rafael; Romero Gutiérrez, Marta; González de Frutos, Concepción; Artaza Varasa, Tomás de; Cruz Perez, Gema de la; Ciampi Dopazo, Juan José; Lanciego Pérez, Carlos; Gómez Moreno, Ana Zaida.
Gastroenterol. hepatol. (Ed. impr.) ; 34(8): 524-531, Oct. 2011.
Artículo en Español | IBECS (España) | ID: ibc-94521

Documentos relacionados

  1. The Systemic Immune Inflammation Index (SII) Combined with the Creatinine-to-Cystatin C Ratio (Cre/CysC) Predicts Sarcopenia in Patients with Liver Cirrhosis Complicated with Primary Hepatocellular Carcinoma.
  2. A Potential Serum <i>N</i>-glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis.
  3. Clinical characteristics, prognosis, and surgical outcomes of patients with non-HBV and non-HCV related hepatocellular carcinoma: three-decade observational study.
  4. A Rare Case of Isolated Hepatocellular Carcinoma Metastasis in Left Mandibular Region in a Patient with Hepatitis C Virus Liver Cirrhosis Diagnosed after the Onset of COVID-19 Infection.
  5. Advances in the Era of Direct-Acting Antivirals for Hepatitis C in Patients with Unresectable Hepatocellular Carcinoma.
  6. Hepatocellular organellar abnormalities following elimination of hepatitis C virus.
  7. Hepatitis C treatment and long-term outcome of patients with hepatocellular carcinoma after resection.
  8. Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
  9. Screening for Hepatocellular Carcinoma in HIV-Infected Patients: Current Evidence and Controversies.
  10. Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals.